Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 7:00 AM CET
Settings

Settings

Goto Application

1. WO2020196992 - COMPOSITION FOR INHIBITING NON-FLUORESCENT ADVANCED GLYCATION END PRODUCTS, AND USE THEREOF

Publication Number WO/2020/196992
Publication Date 01.10.2020
International Application No. PCT/KR2019/008836
International Filing Date 17.07.2019
IPC
A61K 35/744
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K 35/747
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
747Lactobacilli, e.g. L. acidophilus or L. brevis
A23L 33/135 2016.01
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
135Bacteria or derivatives thereof, e.g. probiotics
A23K 10/16 2016.01
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
KFEEDING-STUFFS SPECIALLY ADAPTED FOR ANIMALS; METHODS SPECIALLY ADAPTED FOR PRODUCTION THEREOF
10Animal feeding-stuffs
10obtained by microbiological or biochemical processes
16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
A61P 27/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
12for cataracts
A61P 25/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
CPC
A23K 10/16
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
KFODDER
10Animal feeding-stuffs
10obtained by microbiological or biochemical processes
16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
A23L 33/135
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
135Bacteria or derivatives thereof, e.g. probiotics
A61K 35/744
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K 35/747
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
747Lactobacilli, e.g. L. acidophilus or L. brevis
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 27/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
12for cataracts
Applicants
  • 한국식품연구원 KOREA FOOD RESEARCH INSTITUTE [KR]/[KR]
Inventors
  • 박호영 PARK, Ho Young
  • 김윤숙 KIM, Yoon Sook
  • 오미진 OH, Mi Jin
  • 이상훈 LEE, Sang Hoon
  • 하상근 HA, Sang Keun
  • 최상윤 CHOI, Sang Yoon
  • 박용곤 PARK, Yong Kon
Agents
  • 최은선 CHOI, Eun Sun
Priority Data
10-2019-003313022.03.2019KR
Publication Language Korean (KO)
Filing Language Korean (KO)
Designated States
Title
(EN) COMPOSITION FOR INHIBITING NON-FLUORESCENT ADVANCED GLYCATION END PRODUCTS, AND USE THEREOF
(FR) COMPOSITION POUR INHIBER LES PRODUITS FINAUX DE GLYCATION AVANCÉE NON-FLUORESCENTS, ET SON UTILISATION
(KO) 비형광성 최종당화산물 억제용 조성물 및 이의 용도
Abstract
(EN)
The present invention relates to a composition for inhibiting non-fluorescent advanced glycation end products, and a use thereof. More specifically, the present invention relates to: a composition for inhibiting non-fluorescent advanced glycation end products, comprising one or more strains selected from the group consisting of Lactobacillus sp. strains, Lactococcus sp. strains, Enterococcus sp. strains, Bifidobacterium sp. strains, Bacillus sp. strains, Saccharomyces sp. strains, Pediococcus sp. strains, and Leuconostoc sp. strains; and a food composition, a pharmaceutical composition, a composition for intestinal regulation, a probiotic composition, a feed composition, and a fermented product, which have an activity of reducing non-fluorescent advanced glycation end products and comprise the composition. In addition, the present invention relates to a method for producing a non-fluorescent advanced glycation end product inhibitor and a method for inhibiting non-fluorescent advanced glycation end products.
(FR)
La présente invention concerne une composition destinée à inhiber les produits finaux de glycation avancée non-fluorescents, et une utilisation de ceux-ci. Plus spécifiquement, la présente invention concerne : une composition pour inhiber des produits finaux de glycation avancée non fluorescents, comprenant une ou plusieurs souches choisies dans le groupe consistant en les souches Lactobacillus sp., les souches Lactococcus sp.,les souches Enterococcus sp., les souches Bifidobacterium sp., les souches Bacillus sp., les souches Saccharomyces sp., les souches Pediococcus sp., et les souches Leuconostoc sp. ; et une composition alimentaire, une composition pharmaceutique, une composition pour la régulation intestinale, une composition probiotique, une composition d'aliment, et un produit fermenté, qui ont une activité de réduction de produits finaux de glycation avancée non fluorescents et comprennent la composition. De plus, la présente invention concerne un procédé de production d'un inhibiteur de produit final de glycation avancée non fluorescent et un procédé d'inhibition de produits finaux de glycation avancée non fluorescents.
(KO)
본 발명은 비형광성 최종당화산물 억제용 조성물 및 이의 용도에 관한 것으로, 구체적으로 본 발명은 락토바실러스속 균주, 락토코커스속 균주, 엔테로코커스속 균주, 비피도박테리움속 균주, 바실러스속 균주, 사카로마이에스속 균주, 페디오코커스속 균주 및 루코노스톡속 균주로 이루어진 군 중에서 선택되는 하나 이상의 균주를 포함하는, 비형광성 최종당화산물 억제용 조성물 및 상기 조성물을 포함하는 비형광성 최종당화산물 저감 활성을 갖는 식품 조성물, 약학적 조성물, 정장용 조성물, 생균제 조성물, 사료용 조성물, 발효제품에 관한 것이며, 또한, 본 발명은 비형광성 최종당화산물 억제제의 제조방법 및 비형광성 최종당화산물의 억제방법에 관한 것이다.
Also published as
Latest bibliographic data on file with the International Bureau